Tilray | TRLY - 净收入

股票价格

9.23

每天变化

-0.23 -2.43%

每月一次

-3.75%

每年

1,237.68%

Q2 预测

9.04

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 7.16B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	净收入	更改		日
Acasti Pharma	USD -938K		2.42M	2025-09
Akebia Therapeutics	USD -12.24M		12.78M	2025-12
Alaunos Therapeutics	USD -1.16M		108K	2025-09
Aurora Cannabis	CAD 1.82M		53.29M	2025-12
Avita Medical	AUD -11.62M		1.7M	2025-12
Canopy Growth	CAD -62.63M		60.99M	2025-12
Cronos Group	USD -1.82M		24.14M	2025-12
Dianthus Therapeutics	USD -64.43M		27.67M	2025-12
Divis Laboratories Ltd	INR 5.83B		1.06B	2025-12
Ionis Pharmaceuticals	USD -229M		100.39M	2025-12
IQVIA Holdings	USD 514M		183M	2025-12
Knight Therapeutics	CAD -3.79M		8.83M	2025-09
Moderna	USD -200M		625M	2025-09
Organigram Holdings	CAD 19.97M		57.93M	2025-12
Organon & Co	USD 160M		15M	2025-09
Revvity	USD 98.36M		51.71M	2025-12
Tectonic Therapeutic	USD -19.23M		186K	2025-12
Tilray	USD -44.93M		44.61M	2025-09
Viatris	USD -340.1M		211.9M	2025-12
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12
Zealand Pharma A/S	-379.12M		25.12M	2025-12